Protuoso Biosciences is pioneering innovative multifunctional biologics to address complex diseases with high unmet need
Protuoso Biosciences is pioneering innovative multifunctional biologics to address complex diseases with high unmet need. At the core of its platform are MUXBODIES, fully recombinant fusion proteins that integrate multiple modalities to engage a combination of disease mechanisms. Leveraging AI-enabled protein engineering, computational protein design, and massively parallel synthetic biology, Protuoso discovers and develops first-in-class and best-in-class therapies across cardiometabolic, oncology and autoimmune indications. The company operates under a scalable therapeutic-agnostic hub-and-spoke model, building and optimizing its core protein engineering platform at the hub while advancing therapeutic area-focused assets through disciplined execution and early business development engagement at each spoke. For more information, visit www.protuoso.bio.